Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TSLL vs MRNA✓SelectedUSD · MRNATSLL vs MRNA performance historyLatest closeAs of-15.32%11/20
Stock and ETF performance explorer

TSLL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-60.4%
MRNA return
+10.8%
Excess return
-71.2%
Maximum drawdown
-82.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-15.3%-2.2%-13.1%-15.0%
7D-22.2%-12.7%-9.5%-20.7%
30D-23.3%-20.7%-2.6%-20.9%
3M-8.5%+46.3%-54.7%-13.7%
6M-44.2%+305.2%-349.4%-61.5%
YTD-56.8%+561.2%-618.1%-75.0%
1Y-45.8%+772.1%-817.9%-71.5%
3Y-32.4%+147.0%-179.3%-52.6%
All-60.4%+10.8%-71.2%-65.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling